NSR Nestor Health.

TIDMNSR

RNS Number : 2733Z

Nestor Healthcare Group PLC

11 January 2011

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

11 January 2011

Nestor Healthcare Group PLC ("Nestor" or the "Company")

Rule 2.10 announcement - relevant securities in issue

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Nestor confirms that, as at the close of business on 10 January 2011 the Company had 112,983,758 ordinary shares of 10 pence each in issue on the main market of the London Stock Exchange, under the UK International Securities Identification Number ('ISIN code') GB0006313034.

For further information please contact: Investec Investment Banking Tel: +44 (20) 7597 5970

Martin Smith

Gary Clarence

Cara Griffiths

Citigate Dewe Rogerson Tel: +44 (20) 7638 9571

Toby Mountford

Ged Brumby

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Nestor, all "dealings" in any "relevant securities" of Nestor (including by means of an option in respect of, or a

derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Nestor, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of the Company by the Company, Acromas holdings Limited, other potential offerors for the Company (as referred to in Note 12 on Rule 8), or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RTTEADFFFLLFEFF

Nestor Healthcare (LSE:NSR)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025

Nestor Healthcare (LSE:NSR)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025